It’s too early to tell, but the total artificial heart might be the next potential medtech goldmine. Shares of artificial heart maker Carmat climbed nearly 20% in mid-day trading on September 5 amidst recently-confirmed rumors that the company’s technology had been successfully implanted in the second human patient.
Hey, check out all the engineering jobs. Post your resume today!
